Pentylone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Pentylone
Pentylone.svg
Systematic (IUPAC) name
(±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one
Clinical data
  • US: Schedule I[1]
Identifiers
698963-77-8 YesY
17763-01-8 (hydrochloride)
None
ChemSpider 29786041 N
Chemical data
Formula C13H17NO3
235.278 g/mol
 N (what is this?)  (verify)

β-Keto-Methylbenzodioxolylpentanamine (Pentylone, bk-Methyl-K, bk-MBDP) is a stimulant compound developed in the 1960s,[2] which has been reported as a novel designer drug, identified in some samples of powders sold as "NRG-1", along with varying blends of other substituted cathinone derivatives including flephedrone, MDPBP, MDPV and 4-MePPP. It was also found in combination with 4-MePPP being sold as "NRG-3".[3]

See also[edit]

References[edit]

  1. ^ Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
  2. ^ Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).
  3. ^ Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (December 2010). "Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones". Drug Testing and Analysis 3 (9): 569–75. doi:10.1002/dta.204. PMID 21960541.